Oxford Nanopore Technologies Plc - Company Profile
Powered by 
All the data and insights you need on Oxford Nanopore Technologies Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Oxford Nanopore Technologies Plc Strategy Report
- Understand Oxford Nanopore Technologies Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Oxford Nanopore Technologies Plc (Oxford Nanopore), formerly Oxford NanoLabs Ltd, develops disruptive, electronic, and single-molecule sensing systems. The company’s products include SmidgION, Flongle, MinION, PromethION and GridION used for the analysis of DNA, RNA, proteins, small molecules and other types of molecules. Its products find applications in various areas of research such as microbiology, environmental research, microbiome, basic genome research, human genetics, cancer research, clinical research, plant research, transcriptome analysis, population genomics and animal research. The company also offers support, certification and training services. It works in partnership with various academic and industry research groups to launch new genomic and medical applications through its nanopore technology. Oxford Nanopore is headquartered in Oxford, England, the UK.
Headquarters
United Kingdom
Address
Oxford Science Park, Gosling Building, Edmund Halley Road, England, OX44DQ
Website
www.nanoporetech.com
No of Employees
1,238
Industry
Medical Equipment
Ticker Symbol & Exchange
ONT (LON)
Revenue (2022)
$211.0M
-14.6%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-69.7%
(2022 vs 2021)
Market Cap*
$1.0B
Net Profit Margin (2022)
XYZ
-98.7%
(2022 vs 2021)
* As of and is in US$
Oxford Nanopore Technologies Plc premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| - | Support |
| MinION | Training |
| Gridion-X5 | Certification |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | New Products/Services | In April, the company introduced a compatible products program. |
| 2024 | Contracts/Agreements | In March, the company entered into a partnership with SeqOne to create analytical workflows for rare diseases. |
| 2024 | New Products/Services | In March, the company introduced the PromethION 2 Integrated (P2i). |
Competitor Comparison
| Key Parameters | Oxford Nanopore Technologies Plc | Roche Diagnostics International Ltd | Quest Diagnostics Inc | Illumina Inc | Exact Sciences Corp |
|---|---|---|---|---|---|
| Headquarters | United Kingdom | Switzerland | United States of America | United States of America | United States of America |
| City | Oxford | Rotkreuz | Secaucus | San Diego | Madison |
| State/Province | England | Zug | New Jersey | California | Wisconsin |
| No. of Employees | 1,238 | 2,600 | 40,000 | 10,590 | 6,500 |
| Entity Type | Public | Private | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Duncan Tatton-Brown | Chairman | Executive Board | 2022 | - |
| Gordon Sanghera | Chief Executive Officer; Director | Executive Board | 2005 | - |
| Nick Keher | Chief Financial Officer; Director | Executive Board | 2024 | - |
| Tim Cowper | Chief Operating Officer; Director | Executive Board | 2024 | - |
| Spike Willcocks | Chief Strategy Officer; Director | Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer